Literature DB >> 2839758

Humoral antibody response in patients with herpes genitalis: analysis of factors influencing the pattern of disease.

J A Hallworth1, D I Stocker, D Shariff, D Sugrue, A Buchan, G R Skinner.   

Abstract

An investigation was made of the diagnosis of herpes genitalis, the prediction of virus type and the likelihood and frequency of clinical and asymptomatic recurrences in relation to a history of herpes labialis, the virus type isolated from genital lesions and the humoral antibody status against HSV 1 and 2. Diagnosis of herpes genitalis correlated negatively with mean neutralising antibody levels against HSV type 1 and type 2 but positively with the variance of neutralising antibody levels in sequential sera. Virus type in patients with initial episodes was best predicted by initial and mean type 2 antibody levels and in patients with recurrent disease by the ratio of type 1 to type 2 antibody by radioimmune assay. The likelihood and frequency of clinical and asymptomatic recurrences was higher in patients where HSV type 2 was isolated. The likelihood of recurrences in patients with initial episodes was related to high initial neutralising antibody levels against type 2 and to low primary antibody responses against type 1 while frequency of recurrences was best related to low initial antibody levels against type 1 in combination with high levels against type 2. These data will be useful in diagnosis of herpes genitalis. Prediction of the likelihood and frequency of clinical and asymptomatic recurrences will facilitate advice concerning prognosis and risk factors to patients and their consorts.

Entities:  

Mesh:

Year:  1988        PMID: 2839758     DOI: 10.1007/BF00232894

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  19 in total

1.  A sensitive and precise plaque assay for herpes virus.

Authors:  W C RUSSELL
Journal:  Nature       Date:  1962-09-08       Impact factor: 49.962

2.  Serological relatedness of herpes simplex viruses. Type-specificity of antibody response.

Authors:  G R Skinner; M E Thouless; S Trueman; J Edwards; A J Gibbs
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

3.  Augmentation of the neutralisation test for type 1 HSV: evidence of high representation of neutralising antibody in the adult community.

Authors:  P J Holmes; J A Hallworth; D I Stocker; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

4.  Differentiation between type 1 and type 2 strains of herpes simplex virus by an indirect immunofluorescent technique.

Authors:  L Geder; G R Skinner
Journal:  J Gen Virol       Date:  1971-08       Impact factor: 3.891

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples.

Authors:  D I Bernstein; M A Lovett; Y J Bryson
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

7.  Prevalence of serum antibodies to herpes simplex virus types 1 and 2: application of an ELISA technique to 100 cases of anogenital herpes.

Authors:  A Devillechabrolle; F Hugues-Dorin; B Fortier; F Catalan; J M Huraux
Journal:  Sex Transm Dis       Date:  1985 Jan-Mar       Impact factor: 2.830

8.  Persistence of virus shedding in asymptomatic women after recovery from herpes genitalis.

Authors:  E Adam; R H Kaufman; R R Mirkovic; J L Melnick
Journal:  Obstet Gynecol       Date:  1979-08       Impact factor: 7.661

9.  The polypeptide and the DNA restriction enzyme profiles of spontaneous isolates of herpes simplex virus type 1 from explants of human trigeminal, superior cervical and vagus ganglia.

Authors:  K G Warren; H Koprowski; D M Lonsdale; S M Brown; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

Review 10.  Genital herpes simplex virus infections: clinical manifestations, course, and complications.

Authors:  L Corey; H G Adams; Z A Brown; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.